Will Aeterna Zentaris (USA Stocks:AEZS) continue to drop in June?

Every cloud has a silver lining, and this might just be the case for Aeterna Zentaris (Ticker: AEZS). Despite the company's net income showing a loss of $16.9M and an operating income loss of $18.3M, there are still promising signs for this biotechnology firm. The company's valuation market value stands at $7.8M, with a real value of $12.48M, indicating potential undervaluation. Moreover, the Wall Street target price is set at $15, significantly higher than the 52-week low of $1.36. This suggests that AEZS could still be a promising investment opportunity in the US stock market. Many millennials are steering clear of the biotechnology sector, which brings Aeterna Zentaris into focus. A review of its current market patterns suggests that despite today's solid market gains, the long-term outlook may not be as promising for Aeterna Zentaris. The company's stock price is highly responsive to market trends, with its fluctuations often reflecting broader market movements. Stable core indicators may suggest short-term price shifts for private investors. The company's next financial report is due on May 14, 2024. Currently, Aeterna Zentaris is experiencing above-average trading activity.
Published over six months ago
View all stories for AEZS Old | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

From a technical perspective, Aeterna Zentaris (AEZS) appears to be a risky investment, as evidenced by its high Beta of 2.07 and significant Maximum Drawdown of 298.6. However, the stock's Potential Upside of 8.5 and 50 Day Moving Average of 8.00 suggest some potential for future gains, despite a recent Price Percent Change of -2.99.

Main Points

Aeterna Zentaris stock has an average 'Buy' rating from one analyst. This consensus may be based on technical analysis, which typically uses price momentum, patterns, and trends from historical prices. The goal is to identify signals reflecting the market sentiment of Aeterna Zentaris investors, which is their perception of the company's future value. Let's examine some aspects of Aeterna's technical analysis.
Using predictive technical analysis, we can analyze different prices and returns patterns and diagnose historical swings to determine the real value of AEZS Old. In general, sophisticated investors focus on analyzing AEZS Old stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build AEZS Old's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of AEZS Old's intrinsic value. In addition to deriving basic predictive indicators for AEZS Old, many experienced traders also check how macroeconomic factors affect AEZS Old price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AEZS Old. Your research has to be compared to or analyzed against AEZS Old's peers to derive any actionable benefits. When done correctly, AEZS Old's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AEZS Old.

How does AEZS Stands against Peers?

Analyzing AEZS Old competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to AEZS Old across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out AEZS Old Competition Details

Closer look at Aeterna Zentaris Semi Variance

Aeterna Zentaris has current Semi Variance of 106.0. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi-variance is the square of semi-deviation.
Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Variance

 = 

SUM(RET DEV)2

N(ZERO)

 = 
106.0
SUM = Summation notation
RET DEV = Actual return deviation over selected period
N(ZERO) = Number of points with returns less than zero
Let's now compare Aeterna Zentaris Semi Variance to its closest peers:
AEZS
PULM
ONTX
CBIO
ADIL
AEZS106
PULM7.9
ONTX0.91
CBIO29.74
ADIL57.31
"Buy low, sell high" is a classic investment adage that could potentially apply to Aeterna Zentaris (AEZS). Despite a 52-week low of $1.36, the stock has shown considerable resilience with a current typical day price of $7.96, and a Wall Street target price of $15, indicating a potential upside of 8.5. The company's financial health is robust, with a current ratio of 9.86X, indicating its ability to meet short-term obligations. However, investors should be cautious of the high beta of 2.07, suggesting the stock is more volatile than the market. Despite a net income loss of $16.6M from continuing operations, the company's strong working capital of $31.83M and zero debt to equity ratio could make AEZS a promising investment opportunity..

How will Aeterna private investors react to the next drop?

Aeterna Zentaris' stock has shown a significant decrease in its coefficient of variation, now at 1066.44, indicating reduced volatility and risk. This could potentially attract private investors. However, they should remain alert to any potential downturn that could trigger a sell-off. Despite the reduced volatility, the stock's performance should be closely monitored. Aeterna Zentaris has demonstrated high volatility of returns over the selected period. Understanding market volatility trends can help investors time the market.
Using volatility indicators properly allows traders to measure Aeterna Zentaris' stock risk against market volatility during both bullish and bearish trends. The increased volatility in bear markets can directly affect Aeterna Zentaris' stock price and stress investors as they see their shares' value drop, often leading them to rebalance their portfolios by purchasing different financial instruments as prices fall.In conclusion, Aeterna Zentaris, despite a market gain, has seen a reset of over 2 percent. However, with a valuation market value of 7.8 and a valuation real value of 12.48, the stock still holds potential. The analyst overall consensus leans towards a 'Buy' with one analyst recommending a buy. The possible upside price stands at 48.83, which is significantly higher than the possible downside price of 0.078. The naive expected forecast value is 11.11, indicating a potential for growth. Therefore, investors should consider the potential upside and analyst recommendations when making their investment decisions..

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of AEZS Old. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to [email protected]